Have a personal or library account? Click to login
Does the Course of Disease Influence the Development of Fatigue in Rheumatoid Arthritis Patients? Cover

References

  1. Aletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., Bingham, C. O. 3rd, Birnbaum, N. S., Burmester, G. R., Bykerk, V. P., Cohen, M. D. et al. (2010). 2010 rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum.,62 (9), 2569–2581.10.1002/art.2758420872595
  2. Aletaha, D., Landewe, R., Karonitsch, T., Bathon, J., Boers, M., Bombardier, C., Choi, H., Combe, B., Dougados, M. (2008). Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann. Rheum. Dis., 67 (10), 1360–1364.10.1136/ard.2008.09145418791055
  3. Andersson, M. L. E., Svensson, B., Bergman, S. (2013). Chronic widespread pain in patients with rheumatoid arthritis and the relation between pain and disease activity measures over the first 5 years. J. Rheumatol., 40 (12), 1977–1985.10.3899/jrheum.13049324187108
  4. Bartlett, S. J., Hewlett, S., Bingham, C. O. 3rd, Woodworth, T. G., Alten, R., Pohl, C., Choy, E. H., Sanderson, T., Boonen, A., Bykerk, V., et al. (2012). Identifying core domains to assess flare in rheumatoid arthritis: An OMERACT international patient and provider combined Delphi consensus. Ann. Rheum. Dis., 71, 1855–1860.10.1136/annrheumdis-2011-20120122772326
  5. Bergman, M. J., Shahouri, S. H., Shaver, T. S., Weidensaul, D. N., Busch, R. E., Wang, S., Wolfe, F. (2009). Is fatigue an inflammatory variable in rheumatoid arthritis (RA)? Analyses of fatigue in RA, osteoarthritis, and fibromyalgia. J. Rheumatol., 36, 2788–2794.10.3899/jrheum.09056119918042
  6. Bingham, C. O. III, Gutierrez, A. K., Butanis, A., Bykerk, V. P., Curtis, J. R., Leong, A., Nowell, W. B., Orbai, A. M., Bartlett, S. (2019). PROMIS Fatigue short forms are reliable and valid in adults with rheumatoid arthritis. J. Patient Rep. Outcomes, 3, 14.10.1186/s41687-019-0105-6638428930790155
  7. Breedveld, F. C., Han, C., Bala, M., Heijde, D. van der, Baker, D., Kavanugh, A., Maini, R., Lipsky, P. (2005). Association between baseline radiographic damage and improvement in physical function after treatment of patients with rheumatoid arthritis. Ann. Rheum. Dis., 64, 52–55.10.1136/ard.2003.017160175517415286005
  8. van Delft, M. A. M., Verheul, M. K., Burgers, L. E., Derksen, V. F. A. M., van der Helm-van Mil A. H. M., van der Woude, D., Huizinga, T. W. J., Toes, R. E. M., Trouw, L. A. (2017). The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients. Arthritis Res Ther., 19, 190.10.1186/s13075-017-1392-z555870628810902
  9. Cappelli, L., Barlett, S. J., Jones, M., Bingharm, C. (2015). CCP Antibody negativity is associated with higher fatigue in rheumatoid arthritis (abstract). Arthritis Rheumatol.,67 (suppl 10), 2602. https://acrabstracts.org/abstract/ccp-antibody-negativity-is-associated-with-higher-fatigue-in-rheumatoid-arthritis/ (accessed 14.09.2020).
  10. Demmelmaier, I., Pettersson, S., Nordgren, B., Dufour, A. B., Opava, C. H. (2018). Associations between fatigue and physical capacity in people moderately affected by rheumatoid arthritis. Rheumatol. Int., 38, 2147–2155.10.1007/s00296-018-4140-z620868830159774
  11. Druce, K. L., Bhattacharya, Y., Jones, G. T., Macfarlane, G. J., Basu, N. (2016). Most patients who reach disease remission following anti-TNF therapy continue to report fatigue: Results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Rheumatology (UK), 55, 1786–1790.10.1093/rheumatology/kew24127330158
  12. Hewlett, S., Carr, M., Ryan, S., Kirwan, J., Richards, P., Carr, A., Hughes, R. (2005). Outcomes generated by patients with rheumatoid arthritis: How important are they? Musculoskeletal Care, 3, 131–142.10.1002/msc.317042002
  13. Hewlett, S., Chalder, T., Choy, E., Hewlett, S., Chalder, T., Choy, E., Cramp, F., Davis, B., Dures, E., Nicholls, C., Kirwan, J. (2011). Fatigue in rheumatoid arthritis: Time for a conceptual model. Rheumatology, 50, 1004–1006.10.1093/rheumatology/keq28220819797
  14. Hewlett, S., Cockshott, Z., Byron, M., Kitchen, K., Tipler, S., Pope, D., Hehir, M. (2005). Patients’ perception of fatigue in rheumatoid arthritis: Overwhelming, uncontrollable, ignored. Arthritis Rheum.,53, 697–702.10.1002/art.2145016208668
  15. Holdren, M., Schieir, O., Bartlett, S. J., Bessette, L., Boire, G., Hazlewood, G., Hitchon, C., Keystone, E., Tin, D., Thorne, C., Bykerk, V., Pope, J. (2019). Achieving a low disease state within first 3 months in early rheumatoid arthritis results in lower fatigue over 5 years. Ann. Rheum. Dis., 78 (2), A24010.10.1136/annrheumdis-2019-eular.4414
  16. Hoogmoed, D. van, Fransen, J., Bleijenberg, G., Riel, P. van (2010). Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis. Rheumatology (Oxford), 49, 1294–1302.10.1093/rheumatology/keq04320353956
  17. Jonsson, T., Valdimarsson, H. (1998). What about IgA rheumatoid factor in rheumatoid arthritis? Ann. Rheum. Dis.,57, 63.
  18. Jensen Hansen, I. M., Asmussen Andreasen, R., van Bui Hansen, M. N., Emamifar, A. (2017). The reliability of Disease Activity Score in 28 Joints-C-Reactive Protein might be overestimated in a subgroup of rheumatoid arthritis patients, when the score is solely based on subjective parameters: A cross-sectional, exploratory study. J. Clin. Reum.,23 (2), 102–106.10.1097/RHU.0000000000000469532524427870649
  19. Junghaenel, D. U., Schneider, S., Stone, A. A. (2019). Do people with arthritis differ from healthy controls in their internal comparison standards for self-reports of health, fatigue, and pain? Identification and validation of clinically relevant clusters of severe fatigue in rheumatoid arthritis. J. Patient Rep. Outcomes, 3, 21.
  20. Katz, P. (2017). Fatigue in rheumatoid arthritis. Curr. Rheumatol. Rep., 19, 25.10.1007/s11926-017-0649-528386762
  21. Kirwan, J. R., Minnock, P., Adebajo, A., Bresnihan, B., Choy, E., de Wit, M., Hazes, M., Ricgards, P., Saag, K., Suarez-Almazor, M., Wells, G., Hewlett, S. (2007). Patient perspective: Fatigue as a recommended patient centered outcome measure in rheumatoid arthritis. J. Rheumatol., 34, 1174–1177.
  22. Lacaille, D., White, M. A., Backman, C. L.. Gignac, M. A. M. (2007). Problems faced at work due to inflammatory arthritis: New insights gained from understanding patients’ perspective. Arthritis Care Res., 57, 1269–1279.10.1002/art.2300217907223
  23. Madsen, S. G., Danneskiold-Samsoe, B., Stockmarr, A., Bartels, E. M. (2016). Correlations between fatigue and disease duration, disease activity, and pain in patients with rheumatoid arthritis: A systematic review. Scand. J. Rheumatol., 45, 255–261.10.3109/03009742.2015.109594326690505
  24. Minnock, P., Ringnér, A., Bresnihan, B., Veale, D., FitzGerald, O., McKee, G. (2017) Perceptions of the cause, impact and management of persistent fatigue in patients with rheumatoid arthritis following tumour necrosing factor inhibition therapy. Musculoskel. Care, 15, 23–35.10.1002/msc.113626871999
  25. Nikolaus, S., Bode, C., Taal, E., Laar, M. A. F. J. van der (2013). Fatigue and factors related to fatigue in rheumatoid arthritis: A systematic review. Arthritis Care Res., 65, 1128–1146.10.1002/acr.2194923335492
  26. Pollard, L. C., Choy, E. H., Gonzalez, J., Khoshaba, B., Scott, D. L. (2006). Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology, 45, 885–889.10.1093/rheumatology/kel02116449363
  27. Pope, J. E. (2020). Management of fatigue in rheumatoid arthritis. Rheum. Musculoskel. Dis., Open, 6, e001084.10.1136/rmdopen-2019-001084729951232385141
  28. Primdahl, J., Hegelund, A., Lorenzen, A. G., Loeppenthin, K., Dures, E., Esbensen, B. A. (2019). The experience of people with rheumatoid arthritis living with fatigue: A qualitative meta synthesis. Brit. Med. J. Open, 9, e02433810.
  29. Repping-Wuts, H., Fransen, J., van Achterberg, T., Bleijenberg, G., van Riel, P. (2007). Persistent severe fatigue in patients with rheumatoid arthritis. J. Clin. Nurs., 16 (11C), 377–383.10.1111/j.1365-2702.2007.02082.x17931330
  30. Riemsma, R. P., Rasker, J. J., Taal, E., Griep, E. N., Wouters, J. M., Wiegman, O. (1998). Fatigue in rheumatoid arthritis: The role of self-efficacy and problematic social support. Brit. J. Rheumatol., 37, 1042–1046.10.1093/rheumatology/37.10.10429825741
  31. Rodríguez-Muguruza, S., Combe, B., Guillemin, F., Fautrel, B., Olive, A., Marsal, S., Valero, O., Rincheval, N., Lukas, C. (2020). Predictors of fatigue and persistent fatigue in early rheumatoid arthritis: A longitudinal observational study, data from the ESPOIR cohort. Scand. J. Rheumatol.,49 (4), 259–266.10.1080/03009742.2020.172644932351168
  32. Silva, C. F. R., Duarte, C., Ferreira, R. J. O., Santos, E., Silva, J. A. P. (2019). Depression, disability and sleep disturbance are the main explanatory factors of fatigue in rheumatoid arthritis: A path analysis model. Clin. Exp. Rheumatol., 38, 314–321.10.55563/clinexprheumatol/hkhbad
  33. Shi, J., van de Stadt, L. A., Levarht, E. W., Hizinga, T. W. J., Toes, R. E. M., Trouw, L. A., Schaardenburg, D. van (2013). Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis. Arthritis Rheum.,65, 911–915.10.1002/art.3783023279976
  34. Shi, J., van de Stadt, L. A., Levarht, E. W., Huizinga, T. W., Hamann, D., Schaardenburg, D. van, Toes, R. E. M., Trouw, L. A. (2014). Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis. Ann. Rheum. Dis.,73, 780–783.10.1136/annrheumdis-2013-20415424336334
  35. Strand, V., Jones, T. V., Li, W., Koenig, A. S., Kotak, S. (2015). The impact of rheumatoid arthritis on work and predictors of overall work impairment from three therapeutic scenarios. Int. J. Clin. Rheumatol., 10, 317–328.10.2217/ijr.15.40
  36. Szady, P., Bączyk, G., Kozłowska, K. (2017). Fatigue and sleep quality in rheumatoid arthritis patients during hospital admission. Reumatologia, 55 (2), 65–72.10.5114/reum.2017.67600544229628539677
  37. Truchetet, M. E., Dublanc, S., Barnetche, T., Vittecoq, O., Mariette, X., Richez, C., Blanco, P., Mahler, M., Contin-Bordes, C., Schaeverbeke, T., Fédération Hospitalo-Universitaire ACRONIM. (2017). Association of the presence of anti-carbamylated protein antibodies in early arthritis with a poorer clinical and radiologic outcome: Data from the French ESPOIR cohort. Arthritis Rheumatol., 69, 2292–22302.10.1002/art.4023728853240
  38. Walsh, D. A., McWilliams, D. F. (2014). Mechanisms, impact and management of pain in rheumatoid arthritis. Nat. Rev. Rheumatol., 10, 581–592.10.1038/nrrheum.2014.6424861185
  39. Wolfe, F., Hawley, D. J., Wilson, K. (1996). The prevalence and meaning of fatigue in rheumatic disease. J. Rheumatol., 23, 1407–1417.
  40. Wolfe, F., Michaud, K. (2009). Predicting depression in rheumatoid arthritis: The signal importance of pain extent and fatigue, and comorbidity. Arthritis Care Res., 61, 667–673.10.1002/art.2442819404997
  41. Zielinski, M. R., Systrom, D. M., Rose, N. R. (2019). Fatigue, sleep and auto-immune and related disorders. Front Immunol., 10, 1827.10.3389/fimmu.2019.01827669109631447842
DOI: https://doi.org/10.2478/prolas-2021-0017 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Language: English
Page range: 106 - 112
Submitted on: Sep 22, 2020
Accepted on: Mar 31, 2021
Published on: May 8, 2021
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2021 Anda Kadiša, Zaiga Nora-Krūkle, Lība Sokolovska, Sabīne Grāvelsiņa, Katrīne Vecvagare, Šimons Svirskis, Aivars Lejnieks, Modra Murovska, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.